-Kenneth E Thummel Researcher Activity Profile

Research Author Detailed Information 

Kenneth E Thummel Publication Rate By Year

Kenneth E Thummel has published 2 paper(s) in 2006, 11 paper(s) in 2007, 2 paper(s) in 2008, for a total of 15 research publications in total.

Kenneth E Ke Thummel Author Information

LAST NAME: thummel

FIRST NAME: Kenneth E

INITIALS: ke

AFFILIATION:

Papers

Kenneth E Thummel's Publication Record

1. Determination of free and total cortisol in plasma and urine by liquid chromatography-tandem mass spectrometry. Year Published: 2007
Department of Pharmaceutics, University of Washington, Seattle, Washington, USA.
2. Adding pharmacogenetics information to drug labels: lessons learned. Year Published: 2006
Institute for Genome Sciences & Policy, Duke University, Durham, North Carolina 27708, USA. susanne.haga@duke.edu
3. The dietary isothiocyanate sulforaphane is an antagonist of the human steroid and xenobiotic nuclear receptor. Year Published: 2006
Department of Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98195, USA.
4. Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions. Year Published: 2007
Department of Pharmaceutics, University of Washington, Box 357610, Seattle, WA 98195, USA.
5. Gut instincts: CYP3A4 and intestinal drug metabolism. Year Published: 2007
Department of Pharmaceutics, University of Washington School of Pharmacy, Seattle, Washington 98195-7610, USA. Thummel@u.washington.edu
6. Cytochrome P450 enzymes and transporters induced by anti-human immunodeficiency virus protease inhibitors in human hepatocytes: implications for predicting clinical drug interactions. Year Published: 2007
Department of Pharmaceutics, University of Washington, Box 357610, Seattle, WA 98195, USA.
7. Contribution of Itraconazole Metabolites to Inhibition of CYP3A4 In Vivo. Year Published: 2007
1Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
8. The Influence of CYP3A5 Expression on the Extent of Hepatic CYP3A Inhibition Is Substrate-Dependent: An in Vitro-in Vivo Evaluation. Year Published: 2007
3312 Kerr Hall, CB#7360, School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599-7360. mpaine@med.unc.edu.
9. Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Year Published: 2007
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
10. Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo. Year Published: 2007
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
11. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation. Year Published: 2007
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
12. The influence of CYP3A5 expression on the extent of hepatic CYP3A inhibition is substrate-dependent: an in vitro-in vivo evaluation. Year Published: 2007
Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle, Washington, USA.
13. Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha,25-dihydroxyvitamin D(3) conjugation. Year Published: 2008
Department of Pharmaceutics, University of Washington, Seattle, WA, United States.
14. Identification of human UDP-glucuronosyltransferases catalyzing hepatic 1alpha,25-dihydroxyvitamin D3 conjugation. Year Published: 2008
Department of Pharmaceutics, University of Washington, Seattle, WA, United States.
15. Gut instincts: CYP3A4 and intestinal drug metabolism. Year Published: 2007
Department of Pharmaceutics, University of Washington School of Pharmacy, Seattle, Washington 98195-7610, USA. Thummel@u.washington.edu